DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)
MANUFACTURER: Sanofi - Aventis Groupe
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medicines & Healthcare products Regulatory Agency (MHRA)
Medsafe (NZ)
Rilutek, also known by its generic name Riluzole, is a medication that has brought hope and relief to countless individuals facing the debilitating effects of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.
Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.
Riptropin is an injectable component that is designed to supplement the natural growth hormone in the body. Ideal for people born with the deficiency or in need of higher levels of the natural growth hormone, Riptropin is a high performance component that functions in the same capacity as the natural growth hormone secreted by the pituitary gland in the body which improves body functions.
